Who owns ASLAN PHARMACEUTICALS LTD?
- Ticker: ASLN
- CUSIP Number: 04522r200
Tip: Access positions for across all investors
Analyze quarterly positions in Aslan Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aslan Pharmaceuticals stock
Who bought or sold ASLAN PHARMACEUTICALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 1.0M | $646k | 0% | Mar 2024 |
|
| Velan Capital Investment Management | 625k | $385k | 0% | Mar 2024 |
|
| Shay Capital | 400k | $246k | 0% | Mar 2024 |
|
| Sio Capital Management | 254k | $156k | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 147k | $91k | 432% | Mar 2024 |
|
| Citadel Advisors | 119k | $73k | -76% | Mar 2024 |
|
| ADAR1 Capital Management | 59k | $37k | 100% | Mar 2024 |
|
| FNY Investment Advisers | 47k | $28k | 100% | Mar 2024 |
|
| Millennium Management | 40k | $24k | -51% | Mar 2024 |
|
| Ikarian Capital | 35k | $6.3k | 0% | Mar 2024 |
|
| Onyx Bridge Wealth Group | 23k | $9.4k | 0% | Mar 2024 |
|
| Waterfront Wealth | 21k | $9.1k | -49% | Mar 2024 |
|
| Walleye Trading Advisors | 18k | $11k | 100% | Mar 2024 |
|
| XTX Topco | 12k | $7.6k | 100% | Mar 2024 |
|
| Morgan Stanley | 8.7k | $5.4k | -70% | Mar 2024 |
|
| Bank of America Corporation | 3.0k | $1.9k | 100% | Mar 2024 |
|
| Capital Analysts | 2.0k | $999.925600 | 0% | Mar 2024 |
|
| Rhumbline Advisers | 1.3k | $793.998400 | 0% | Mar 2024 |
|
| Cutler | 1.2k | $0 | 20% | Mar 2024 |
|
| Qube Research & Technologies | 34.00 | $20.998400 | -85% | Mar 2024 |
|
Who sold out of Aslan Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2023 | 625k | $326k |
| Parkman Healthcare Partners | Sep 2023 | 373k | $701k |
| Landscape Capital Management | Dec 2023 | 83k | $44k |
| Jane Street | Dec 2023 | 23k | $12k |
| Simplex Trading | Dec 2023 | 1.2k | $0 |